I've written about explicitly connecting cost-effectiveness analysis to notions of "value" in US health policy (and have certainly tweeted about it). Now here is a glossy 5-minute video of me talking through the idea (with drawing!):

RT @jinyizhu_: 🚨Thrilled to share our new JAMA Neurology publication! Building on previous work, we compare the past vs. future impact of s…

RT @jinyizhu_: So proud of our former RA Astrid @hanxuan_yu gearing up for an awesome talk at #SMDM24! Don’t miss her talk on how sampling…

@Andrew___Baker @PeterNeumann11 @NataliaKunst @TuftsCEVR @DukeMargolis @socmdm @decisionscience @drmengli @PSynnott29 @WrightCensored @ddkim62 @UW_Pharmacy @GSchmidler I was gonna give them this photo and thought "too happy"

@NataliaKunst @Andrew___Baker @PeterNeumann11 @TuftsCEVR @DukeMargolis @socmdm @decisionscience @drmengli @PSynnott29 @WrightCensored @ddkim62 @UW_Pharmacy @GSchmidler 😭 around David yes

RT @TuftsCEVR: 1/3: Thrilled to share topics/moderators for panel discussions at our upcoming 10/26 special symposium on #CEA: CEA’s Evolu…

@WrightCensored I've also stopped going high 😂

@LaurawherryR he's okay

@katherinemrich @EmilyHyle @aimaMDMPH @Keyosee @NeilanAnne @PinkneyJodian @aciaranello @mgh_mpec great thread!

@Andy_Ryan_dydx @efusebrown @cyruskosar @CM_Whaley @ysingh_hopkins @ambilinski @instrumenthull @djmeyers2 re-logged onto twitter to appreciate the white patch on your cartoon beard